Ameriprise’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $610K | Buy |
95,219
+82,414
| +644% | +$528K | ﹤0.01% | 3428 |
|
|
2025
Q1 | $45.3K | Sell |
12,805
-37,623
| -75% | -$133K | ﹤0.01% | 3914 |
|
|
2024
Q4 | $191K | Buy |
+50,428
| New | +$191K | ﹤0.01% | 3851 |
|
|
2023
Q4 | – | Sell |
-129,918
| Closed | -$2.38M | – | 3898 |
|
|
2023
Q3 | $2.38M | Sell |
129,918
-254
| -0.2% | -$4.65K | ﹤0.01% | 2742 |
|
|
2023
Q2 | $2.81M | Sell |
130,172
-82,281
| -39% | -$1.77M | ﹤0.01% | 2703 |
|
|
2023
Q1 | $6.23M | Buy |
212,453
+8,377
| +4% | +$246K | ﹤0.01% | 2164 |
|
|
2022
Q4 | $7.54M | Buy |
204,076
+136,201
| +201% | +$5.03M | ﹤0.01% | 1987 |
|
|
2022
Q3 | $1.91M | Sell |
67,875
-31,080
| -31% | -$875K | ﹤0.01% | 2803 |
|
|
2022
Q2 | $1.91M | Buy |
98,955
+16,645
| +20% | +$321K | ﹤0.01% | 2828 |
|
|
2022
Q1 | $1.06M | Buy |
+82,310
| New | +$1.06M | ﹤0.01% | 3190 |
|